Leon Eisen, PhD

https://www.linkedin.com/in/leoneisen/

https://twitter.com/leon_eisen

I am an inventor, serial entrepreneur, CEO and Chairman, Senator at the Grand Assembly of the World Business Angel Investment Forum (an affiliated partner of the G20 and a leading global angel investment organization), strategic adviser, and speaker with 20+ years of strong technology, business and leadership experience. I am an affiliated member of the Royal Society of Medicine (UK), a member of the Forbes Business Council, and an official mentor at the Israeli Export Institute.
Passionate about healthcare digital transformation, I invented the world's first, awards-winning FDA-cleared wrist pulse oximetry monitor. To commercialize my invention, I founded Oxitone Medical and raised the first $1,000,000 seed investment in the middle of the 2008 economic crisis. I was leading the company as a CEO through product development and several investment rounds to the growth stage. The company, technology, and product received significant healthcare industry recognition resulting in a number of prominent rewards and Oxitone was included in the 2015 Global Digital Health100 companies.
I hold a Ph.D. in physics from the Weisman Institute of Science (Israel) and studied entrepreneurship at the Harvard Business School. I have a long list of successfully delivered products, more than 30 patents worldwide, and published over 20 scientific publications.
Combining my background in quantum physics with hands-on entrepreneurial experience and real-world business sense, I developed a winning QUANTUM BACKWARD THINKING business strategy that enables founders to create their OWN REALITY on demand with 100% predictive results.
As an official mentor at the Israel Export and International Cooperation Institute, I counsel early-stage startups and growth companies on the strategy of goal setting, optimal structuring, business models, board management, team building, business processes, R&D and product development, design thinking, regulation and other strategic issues, primarily in the artificial intelligence, digital health and medical device sectors.